These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2578841)

  • 1. High-dose intravenous gamma globulin in alloimmunized platelet transfusion recipients.
    Knupp C; Chamberlain JK; Raab SO
    Blood; 1985 Mar; 65(3):776. PubMed ID: 2578841
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immune globulin for patients alloimmunized to random donor platelet transfusion.
    Lee EJ; Norris D; Schiffer CA
    Transfusion; 1987; 27(3):245-7. PubMed ID: 3590287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High-dose intravenous gamma globulin therapy for acute leukemia refractory to platelet transfusions].
    Sano M; Nakamaki T; Miyashita T; Tomoyasu S; Tsuruoka N
    Rinsho Ketsueki; 1985 Sep; 26(9):1496-500. PubMed ID: 2418224
    [No Abstract]   [Full Text] [Related]  

  • 4. High dose intravenous gammaglobulin and platelet transfusions in leukaemic HLA-immunized patients.
    Bierling P; Cordonnier C; Rodet M; Vernant JP; Pesce A; Rochant H; Duedari N
    Scand J Haematol; 1984 Aug; 33(2):215-20. PubMed ID: 6206554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of idiopathic thrombocytopenic purpura responding to high-dose globulin therapy following platelet transfusion with globulin therapy].
    Kawagoe H; Matsubuchi T; Hirata A
    Rinsho Ketsueki; 1987 Oct; 28(10):1872-5. PubMed ID: 2455074
    [No Abstract]   [Full Text] [Related]  

  • 6. High-dose intravenous gamma globulin improves responses to single-donor platelets in patients refractory to platelet transfusion.
    Zeigler ZR; Shadduck RK; Rosenfeld CS; Mangan KF; Winkelstein A; Oral A; Ramsey GE; Duquesnoy RJ
    Blood; 1987 Nov; 70(5):1433-6. PubMed ID: 2444288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-day intravenous therapy with high-dose gamma-globulin for idiopathic thrombocytopenic purpura.
    Sasaki A; Furukawa Y; Inoue T; Yamane T; Sannomiya Y; Im T; Tatsumi N
    Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):147-9. PubMed ID: 2472726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial measurement of lymphocytotoxic antibody and response to nonmatched platelet transfusions in alloimmunized patients.
    Lee EJ; Schiffer CA
    Blood; 1987 Dec; 70(6):1727-9. PubMed ID: 3479195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized.
    Dutcher JP; Schiffer CA; Aisner J; Wiernik PH
    Blood; 1981 Nov; 58(5):1007-11. PubMed ID: 6794674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
    Amemiya Y
    Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The preparation of gamma-globulin for intravenous use in Paris.
    Steinbuch M; Audran R; Amouch P; Blatrix C
    Vox Sang; 1967 Jul; 13(1):103-6. PubMed ID: 4166587
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized, placebo-controlled trial of intravenous gammaglobulin in alloimmunized thrombocytopenic patients.
    Kickler T; Braine HG; Piantadosi S; Ness PM; Herman JH; Rothko K
    Blood; 1990 Jan; 75(1):313-6. PubMed ID: 1688499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of HLA-Bw4 antibody in an alloimmunized patient with nonlymphocytic leukemia].
    Ryo R; Hashimoto M; Saigo K; Nakaya Y; Yamaguchi N
    Rinsho Ketsueki; 1985 Dec; 26(12):1974-8. PubMed ID: 3834162
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of antibody deficiency syndromes with subcutaneous infusion of gamma globulin.
    Roord JJ; van der Meer JW; Kuis W; van Furth R
    Birth Defects Orig Artic Ser; 1983; 19(3):217-21. PubMed ID: 6197108
    [No Abstract]   [Full Text] [Related]  

  • 16. [High-dose intravenous gamma globulin therapy in collagen diseases].
    Hokonohara M
    Ryumachi; 1986 Jun; 26(3):189-99. PubMed ID: 2431488
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of chronic idiopathic thrombocytopenic purpura (ITP) with high-dose intravenous gamma globulin.
    Duran-Suarez JR; Martin A; Botella MC; de la Torre S; Bailen A; Maldonado J
    Haematologica; 1983; 68(4):564-6. PubMed ID: 6195053
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy with high-dose intravenous gamma globulin in the newborn infant with thrombocytopenia from passive immunization].
    Ronconi GF; Castaman G; Fantuz E; Rodeghiero F
    Pediatr Med Chir; 1985; 7(4):567-8. PubMed ID: 2426684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous gamma globulin therapy.
    Good RA
    J Clin Immunol; 1982 Apr; 2(2 Suppl):48S. PubMed ID: 6177710
    [No Abstract]   [Full Text] [Related]  

  • 20. The predictive value of crossmatching platelet transfusion for alloimmunized patients.
    Kickler TS; Braine H; Ness PM
    Transfusion; 1985; 25(4):385-9. PubMed ID: 4024239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.